Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-21

Clinical Trial Update: Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Triamcinolone with Pentoxifylline and Vitamin E for treatment of stage 2 and 3 Oral Submucous Fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)
  • Triamcinolone (triamcinolone)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Altamash Institute of Dental Medicine | Conditions: Triamcinolone, Pentoxifylline | Phase 4 | Status: COMPLETED